Announcements
- New commercial agreement with AstraZeneca
- US and EU patents for innovative CellKeepâ„¢ slide
- Parsortix HER2 assay showcased at AACR 2024
- Parsortix at European breast cancer conference
- Potential utility in precision oncology
- Standard form for notification of major holdings
- Breakthrough clinical results
- Contract announcement with Eisai Inc.
- Broker Announcement
- Parsortix unlocks opportunities for drug discovery
More ▼
Key statistics
As of last trade, Angle PLC (ANPCY:QXE) traded at 1.89, 67.33% above the 52 week low of 1.13 set on Nov 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.89 |
---|---|
High | 1.89 |
Low | 1.89 |
Bid | -- |
Offer | -- |
Previous close | 1.89 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Apr 29 2024 14:30 BST.
More ▼